ReSPECT-LM: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (clinicaltrials.gov) - Aug 14, 2023 - P1 | N=18 | Recruiting | Sponsor: Plus Therapeutics | Trial completion date: Dec 2023 ➔ Jun 2026 | Trial primary completion date: Jul 2023 ➔ Dec 2025
Trial completion date • Trial primary completion date • Oncology
|